Tri-State Pain Institute Among First Pain Clinics To Use Non-Opiod Treatment For Chronic Pain

- April 3, 2018

Spectra WaveWriter™ Spinal Cord Stimulator System allows patients to combine therapeutic options and customize treatment 

Tri-State Pain Institute in Erie, Pa., is among the first pain clinics to offer the Spectra WaveWriter™ Spinal Cord Stimulator System to patients with chronic pain. It is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception stimulation, two therapies used in providing pain relief. Paresthesia-based therapy provides pain relief with a light tingling sensation while sub-perception therapy works without that sensation.

According to Dr. Joseph Thomas, director and founder of the Pain Institute, spinal cord stimulation (SCS) is an FDA approved non-opioid treatment option for people with chronic pain in the legs and back. The device sends low electrical pulses to the spinal cord that interrupt pain signals.  Two thin wires, called leads, are implanted in the spine and powered by a rechargeable battery which is implanted in the chest.

With the Spectra WaveWriter System, patients can combine both of these therapies to target one specific area of pain or use each therapy as needed to best manage multiple areas of pain. Patients provide real-time feedback using the system’s remote control. The Spectra WaveWriter System was developed with more than a decade of clinical research focused on optimizing sub-perception stimulation and delivering multiple therapies intended for more effective, long-term pain relief.

“Everyone experiences pain differently and patients can sometimes become less responsive to therapy as their pain changes over time,” said Dr. Timothy Ko, interventional pain specialist at Tri-State Pain. “The Spectra WaveWriter System is breakthrough technology that offers patients flexibility to meet their individual needs for lasting relief. Treatment options like this are important as we face the challenge of providing patients relief from pain without relying solely on opioids.”

More than 100 million Americans suffer from chronic pain and it is the number one cause of disability in adults in the U.S. SCS was introduced more than 40 years ago. Unlike most surgical procedures, it is reversible. Patients undergo a trial period allowing them to evaluate it before deciding to receive a permanent implant.

To learn more, contact Tri-State Pain Institute at 814-833-7246.